The Pete Williams Lab uses the eye as a model of the central nervous system to elucidate early mechanisms of neurodegeneration. Our current focus is the glaucoma. My lab utilizes modern transcriptomic and molecular tools to delicately dissect pathways pertaining to early aging and neurodegenerative disease mechanisms and to identify potential therapeutic targets which we then test and verify in animal and cell models of neurodegeneration. The strengths of my group include neurobiology and molecular biology techniques, gene therapy, electrophysiology, and –omics data generation and analysis.